SHC - Sotera Health Company
Algert Global LLC lowered its position in Sotera Health Company (NASDAQ: SHC) by 15.6% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 361,280 shares of the company's stock after selling 66,610 shares during the period. Algert Global
BlackRock Inc. acquired a new stake in shares of Sotera Health Company (NASDAQ: SHC) during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 24,148,424 shares of the company's stock, valued at approximately $428,635,000. BlackRock Inc. owned approximately 8.47% of Sotera
Deutsche Bank AG purchased a new position in shares of Sotera Health Company (NASDAQ: SHC) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 379,908 shares of the company's stock, valued at approximately $6,743,000. Deutsche Bank AG
Sotera Health (NASDAQ: SHC - Get Free Report) and WuXi AppTec (OTCMKTS:WUXIF - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, profitability and earnings. Insider and Institutional Ownership 91.0% of Sotera Health
Bank of America Corp DE lifted its stake in shares of Sotera Health Company (NASDAQ: SHC) by 332.7% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,289,649 shares of the company's stock after buying an additional 991,620 shares during the period. Bank
California State Teachers Retirement System raised its stake in Sotera Health Company (NASDAQ: SHC) by 21.6% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 248,642 shares of the company's stock after purchasing an additional 44,092 shares during the quarter.
Sotera Health NASDAQ: SHC reported second-quarter 2026 results that included 8% constant-currency revenue growth, higher adjusted EBITDA margins and an increase to its full-year revenue and adjusted EBITDA outlook.
Sotera Health Company (SHC) Q2 2026 Earnings Call Transcript
Although the revenue and EPS for Sotera Health (SHC) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Sotera Health Company (SHC) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.2 per share a year ago.
Q2 2026 net revenues increased 9.2% or 8.0% on a constant currency basis (1) compared to Q2 2025 Q2 2026 net income of $54 million or $0.19 per diluted share, compared to net income of $8 million or $0.03 per diluted share in Q2 2025 Q2 2026 Adjusted EBITDA ( 1 ) increased 10.0%, or 8.7% on a constant currency basis Q2 2026 Adjusted EPS (1) of $0.26, an increase of 30% per diluted share Company raises both full-year 2026 net revenues growth out look to 5.25% - 6.75% and Adjusted EBITDA growth outlook to 5.75% - 7.25%, on a constant currency basis CLEVELAND, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three- and six- months ended June 30, 2026. “We delivered another strong quarter, with high-single-digit growth, reflecting focused execution across all three of our business units,” said Chief Executive Officer Alton Shader.
Dimensional Fund Advisors LP lifted its stake in Sotera Health Company (NASDAQ: SHC) by 6.9% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,518,875 shares of the company's stock after purchasing an additional 358,281 shares during the
Bank of New York Mellon Corp lifted its stake in Sotera Health Company (NASDAQ: SHC) by 13.4% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,403,971 shares of the company's stock after purchasing an additional 166,055 shares during the period.
CLEVELAND, July 23, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the second-quarter ended June 30, 2026 before the market opens on Thursday, August 6, 2026. Following the release, management will host a conference call at 9:00 a.m.
Sotera Health Company (SHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Sotera Health Company (SHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
CLEVELAND, May 11, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 31,838,253 shares of its common stock, par value $0.01 per share. All 31,838,253 shares are being offered for sale by certain affiliates of Warburg Pincus LLC (“Warburg Pincus”) and GTCR LLC (“GTCR”) as selling stockholders.
Sotera Health offers sterilization and lab testing for healthcare and life sciences clients, supporting global regulatory compliance.
Sotera Health Company (SHC) Q1 2026 Earnings Call Transcript